Investing.com - CVS再次上调了其全年利润预测，该集团表示这得益于其医疗保健福利以及药房和消费者健康部门的强劲表现。 在10月接任公司掌舵人的首席执行官David ...

CVS Health (NYSE: CVS )在7月31日发布2025财年第二季度业绩后，盘前股价跃升7.38%。这家医疗保健巨头展示了强劲的收入增长，并提高了全年展望。公司报告的合并收入为989亿美元，较去年同期增长8.4%。

智通财经APP获悉，西维斯健康 (CVS.US)周四公布的第二季度利润和营收均超市场预期，并上调了全年调整后利润指引，这主要得益于其零售药房业务的强劲表现和保险业务的改善。受此提振，这家连锁药房巨头股价盘前一度大涨逾9%。

While competitors continue to struggle with spiraling healthcare costs, Aetna and CVS are celebrating an 8.4% increase in second-quarter revenues. The insurer is achieving this through nimble ...

CVS CEO David Joyner pointed to strength in its retail pharmacy and improvement in its insurance unit, Aetna, which is ...

Investing.com - CVS has once again raised its full-year profit forecast, as the conglomerate said it was boosted by strength ...

CVS Health Corp. raised its profit guidance for the year after posting strong results in its health insurance and pharmacy ...

The optimistic sign of recovery sent shares of the company nearly 8% higher in premarket trading, as it followed ...

CVS Health beat Wall Street estimates for second-quarter profit on Thursday, as tight oversight of higher medical costs led ...

When the company reports its second-quarter earnings results on Thursday, investors will be watching to see whether it can ...

CVS beats Q2 earnings and revenue estimates, lifts full-year forecast. Stock surges over 8% in premarket trading, up 39% YTD.

CVS beat Wall Street estimates in its second quarter earnings Thursday, bringing relief to a stock under pressure from higher ...